Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
03/2012
03/29/2012US20120077838 Beta-2-Adrenoreceptor Agonists
03/28/2012EP2432760A1 Bridged spiro [2.4]heptane derivatives as alx receptor and/or fprl2 agonists
03/28/2012EP1951690B1 Heterocyclic cetp inhibitors
03/28/2012EP1499580B1 Compounds that stimulate glucose utilization and methods of use
03/28/2012CN102395563A Process for the preparation of a biphenyl-2-ylcarbamic acid ester
03/28/2012CN102395558A Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
03/28/2012CN102391147A Preparation and activity of aryl formyl amino cyclopropanecarboxylic acid
03/28/2012CN102391146A Preparation method of racecadotril intermediate 2-(benzyl acrylamide) benzyl acetate
03/28/2012CN102391145A Method for resolving optical isomer of ubenimex intermediate conveniently
03/28/2012CN102391144A Synthetic method of (R)-oleoyl propanolamine
03/28/2012CN102391143A Method for preparing broad-spectrum antibiotic chloramphenicol
03/28/2012CN102389409A TRP-P8 active compounds and therapeutic treatment methods
03/28/2012CN101781226B Agomelatine and medicine composition thereof
03/28/2012CN101704763B Preparation method of agomelatine I type crystal
03/28/2012CA2715907A1 Group 5 metal complexes useful for amine functionalization and synthetic process for manufacture thereof
03/27/2012US8143449 Process for the synthesis of agomelatine
03/27/2012US8143448 Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives
03/27/2012US8143447 Treatment of cancer
03/27/2012US8143445 HDAC inhibitors
03/22/2012WO2012034991A1 Method for producing formamides
03/22/2012WO2012016314A9 Arachidonic acid-derived coxib analogue-substituted compounds for use in treating pain
03/22/2012US20120071654 Aryl aniline derivatives as beta2 adrenergic receptor agonists
03/22/2012US20120071651 Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives
03/22/2012US20120070511 Mitochondrial inhibitors and uses thereof
03/22/2012CA2811265A1 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
03/21/2012EP2431355A1 New crystalline form vi of agomelatine, preparation method and application thereof
03/21/2012EP2429986A1 Haloalkyl heteroaryl benzamide compounds
03/21/2012EP2004593B1 Improved crystalline material
03/21/2012EP1954668B9 Homo- and heterocyclic compounds suitable as cetp inhibitors
03/21/2012EP1776011B1 Fungicidal composition containing an acid amide derivative
03/21/2012EP1608339B1 Pharmaceutical co-crystal of celecoxib-nicotinamide
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102382005A Propofol ester derivative containing amino carboxylic acid amide structure, its preparation method and its purpose
03/21/2012CN102382004A Decolorization pre-treatment system and decolorization pre-treatment method of acetaminophen
03/21/2012CN102382003A Preparation method of long-chain fatty acyl ethanolamine
03/21/2012CN101880242B Method for preparing 3-amino-4-methoxyacetanilide by taking Raney nickel as catalyst
03/21/2012CN101260064B Technique for producing N.N-ethylene bisoleamide
03/21/2012CN101239927B Method for preparing monomer of temperature-sensitive polyisopropylacrylamide
03/21/2012CN101225052B Process for extracting and separating capsaicin, capsicum red pigment and capsicum oleoresin crude product from red pepper
03/21/2012CN101184725B N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
03/20/2012US8138375 Method for producing 1-formamido-3,5-dimethyladamantane
03/20/2012US8138374 Composition for external application to skin
03/20/2012US8138373 Process for the manufacture of dihydropteridinones
03/20/2012US8138218 Growth hormone secretagogues
03/20/2012CA2513583C Modified retinoid compounds and their uses
03/20/2012CA2444463C Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/15/2012WO2012031466A1 2-(p-octylphenylethyl)-2-amino propanediol derivatives and uses thereof
03/15/2012WO2011146610A3 An enantioselective synthesis of chiral amines for the production of rotigotine
03/15/2012US20120065367 Radioactively Labeled Substance
03/15/2012US20120065299 Reactive graphtic carbon nanofiber reinforced polymeric composites
03/15/2012US20120065204 Novel n-hydroxy-benzamids for the treatment of cancer
03/14/2012EP2428504A1 Small molecule inhibitors of the pleckstrin homology domain and method for using same
03/14/2012EP2428503A1 Synthesis of tripodal catechol derivatives with a flexible base for functionalising surfaces
03/14/2012EP2428502A1 Synthesis of tripodal catechol derivatives with an adamantyl base for functionalising surfaces
03/14/2012EP2231590B1 Antitumoral compounds
03/14/2012EP2103601B1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
03/14/2012CN102378753A Plasminogen activator inhibitor-1 inhibitor
03/14/2012CN102373051A Binary composite oil displacement agent and preparation method thereof
03/14/2012CN102372648A Polymerizable functional monomer and synthesis method thereof
03/14/2012CN102372647A Free radical polymerization functional monomer and synthesis method thereof
03/14/2012CN102372646A Synthesis method for amide derivative
03/14/2012CN101519362B Method for recovering dimethyl formamide
03/14/2012CN101260066B Method for producing fatty acid amide from cocoanut oil acidifying oil
03/13/2012US8134029 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
03/13/2012US8134026 Process for the preparation of Cilastatin and sodium salt
03/13/2012US8133515 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
03/13/2012US8133514 Carbon-substituted diketopiperazine delivery systems
03/13/2012CA2643097C Amine derivatives
03/13/2012CA2435126C Process
03/08/2012WO2012029968A1 Benzamide derivative or its salt, and insecticide, miticide, nematicide or soil pesticide containing it
03/08/2012WO2012029794A1 Aromatic compound containing specific branch
03/08/2012WO2012029672A1 Noxious organism control agent
03/08/2012WO2012029276A1 Recording material using phenol compound
03/08/2012WO2012028676A1 New compounds, pharmaceutical compositions and uses thereof
03/08/2012WO2011139765A3 Compounds that modulate intracellular calcium
03/08/2012US20120059149 Branched chain-containing aromatic compound
03/08/2012US20120059055 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058063 Process for treating and/or forming a non-newtonian fluid using microchannel process technology
03/08/2012CA2808144A1 Pest control agent
03/07/2012EP2426103A1 Method for producing alpha, beta-unsaturated carboxylic acid-n,n-disubstituted amide and method for producing 3-alkoxycarboxylic acid-n,n-disubstituted amide
03/07/2012EP2425715A1 Treating symptoms of renal disease with selective androgen receptor modulators (SARM)
03/07/2012CN102369181A Method for continuously producing alkylamino(meth)acrylamides
03/07/2012CN102367229A Ethylenediamine diaceturate compound and pharmaceutical composition thereof
03/07/2012CN102367228A Method for synthesizing agomelatine
03/07/2012CN101139520B Method for preparing alkanolamide and its application in teritary oil extraction
03/06/2012US8129566 Polycationic compounds and uses thereof
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/01/2012WO2012026886A1 Chalcone structure fluorescence dye for embryonic stem cell probe
03/01/2012WO2012026743A2 Labeling agent and amino acid sequence using same, and method for performing simultaneous quantitative analysis of multiple proteins
03/01/2012WO2012026639A1 Novel compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient
03/01/2012WO2012026403A1 Condensed ring compound
03/01/2012US20120053246 Purification process for preparing highly pure arformoterol tartrate substantially free of desformyl impurity
03/01/2012US20120053244 Alkylamido Compounds and Uses Thereof
03/01/2012US20120053243 Parakeratosis inhibitor and skin preparation for external use
03/01/2012US20120052757 Molecularly imprinted polymers
02/2012
02/29/2012EP2421820A1 Compounds having a physiological effect
02/29/2012EP2421375A2 Chemical and biological agents for the control of molluscs
02/29/2012EP2094643B1 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 289